Ivermectin for Covid-19
Description
Discussion of scholar papers published until end of June and beginning of July, 2020, on Ivermectin, and of news that we can find about its use for Covid-19. A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. From news, we consider in particular the case of Iquitos, capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government. A section about updating (8 July) is added to the discussion.
Notes
Files
Ivermectin-10.pdf
Files
(283.2 kB)
Name | Size | Download all |
---|---|---|
md5:1df9173b41d6012668936519c449b494
|
283.2 kB | Preview Download |